CASELLA, Michela
 Distribuzione geografica
Continente #
NA - Nord America 7.889
EU - Europa 1.882
AS - Asia 812
AF - Africa 197
Continente sconosciuto - Info sul continente non disponibili 18
SA - Sud America 13
OC - Oceania 1
Totale 10.812
Nazione #
US - Stati Uniti d'America 7.875
IE - Irlanda 558
SG - Singapore 344
CN - Cina 343
IT - Italia 317
DE - Germania 227
SE - Svezia 224
UA - Ucraina 203
FR - Francia 161
MA - Marocco 139
IN - India 110
GB - Regno Unito 102
CI - Costa d'Avorio 55
FI - Finlandia 24
RO - Romania 22
EU - Europa 17
BE - Belgio 16
CA - Canada 13
BR - Brasile 10
NL - Olanda 6
AT - Austria 4
HK - Hong Kong 4
KR - Corea 4
PL - Polonia 3
PT - Portogallo 3
CH - Svizzera 2
EC - Ecuador 2
LT - Lituania 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
ES - Italia 1
GH - Ghana 1
JP - Giappone 1
LI - Liechtenstein 1
MD - Moldavia 1
MX - Messico 1
NO - Norvegia 1
PH - Filippine 1
PK - Pakistan 1
PS - Palestinian Territory 1
RS - Serbia 1
TN - Tunisia 1
TR - Turchia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.812
Città #
Des Moines 922
Fairfield 827
Chandler 759
Ashburn 692
Jacksonville 653
Dublin 549
Boardman 396
Woodbridge 373
Wilmington 345
Seattle 319
Houston 308
Cambridge 279
Lawrence 195
Princeton 195
San Mateo 169
Ann Arbor 163
New York 148
Pune 104
Singapore 104
San Diego 83
Washington 76
Los Angeles 63
Redmond 61
Ancona 60
Abidjan 55
Beijing 48
Dallas 44
London 42
Turin 41
Guangzhou 26
Helsinki 24
Shanghai 24
Norwalk 16
Tolentino 16
Brussels 15
Wuhan 14
Frankfurt am Main 12
Kilburn 12
Falls Church 11
Nanjing 10
Shenzhen 10
Milan 9
Jiaxing 8
Jinhua 8
Santa Clara 8
Centro 7
Civitanova Marche 7
Rome 7
Cedar Knolls 6
Hangzhou 6
Padova 6
Hounslow 5
Munich 5
New Bedfont 5
Ottawa 5
Prescot 5
Auburn Hills 4
Edinburgh 4
Fayetteville 4
Gualdo Tadino 4
Heze 4
Lucera 4
Phoenix 4
Toronto 4
Yiwu 4
Bologna 3
Cantù 3
Cerreto d'Esi 3
Changsha 3
Clifton 3
Fuzhou 3
Miami 3
Naples 3
Palermo 3
Paris 3
Seoul 3
Southwark 3
Stockholm 3
Vienna 3
Zibo 3
Amsterdam 2
Arcore 2
Assemini 2
Bari 2
Boydton 2
Catania 2
Chengdu 2
Chicago 2
Chongqing 2
Cusano Milanino 2
Dongguan 2
Fermo 2
Grottammare 2
Guastalla 2
Guayaquil 2
Handan 2
Harbin 2
Hong Kong 2
Huizhou 2
Kansas City 2
Totale 8.481
Nome #
Differentiating hereditary arrhythmogenic right ventricular cardiomyopathy from cardiac sarcoidosis fulfilling 2010 ARVC Task Force Criteria 140
Characteristics of Patients With Arrhythmogenic Left Ventricular Cardiomyopathy: Combining Genetic and Histopathologic Findings 130
Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on a Tertiary-Level Electrophysiology Laboratory in Italy 129
Long-Term Arrhythmic Risk Assessment in Biopsy-Proven Myocarditis 124
Cardiac arrhythmia catheter ablation procedures guided by x-ray imaging: N-acetylcysteine protection against radiation-induced cellular damage (CARAPACE study): study design 123
Clinical management of electrical storm 118
A randomized double-blind comparison of biventricular versus left ventricular stimulation for cardiac resynchronization therapy: The Biventricular versus Left Univentricular Pacing with ICD Back-up in Heart Failure Patients (B-LEFT HF) trial 113
Role of cardiac imaging in patients undergoing catheter ablation of ventricular tachycardia 108
Cyclophilin a in arrhythmogenic cardiomyopathy cardiac remodeling 105
Recent advances in three-dimensional electroanatomical mapping guidance for the ablation of complex atrial and ventricular arrhythmias 105
Prior myocarditis and ventricular arrhythmias: the importance of scar pattern 100
Diagnostic Yield of Electroanatomic Voltage Mapping in Guiding Endomyocardial Biopsies 88
Novel risk calculator performance in athletes with arrhythmogenic right ventricular cardiomyopathy 81
Procedural sedation for direct current cardioversion: a feasibility study between two management strategies in the emergency department 81
Prospective use of ablation index for the ablation of right ventricle outflow tract premature ventricular contractions: a proof of concept study 80
Arrhythmogenic Cardiomyopathy: the Guilty Party in Adipogenesis 77
Clinical and Molecular Data Define a Diagnosis of Arrhythmogenic Cardiomyopathy in a Carrier of a Brugada-Syndrome-Associated PKP2 Mutation 76
Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: Arrhythmia-free survival after endo-epicardial substrate based mapping and ablationablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy arrhythmia-free survival after endo-epicardial substrate based mapping and ablation 72
Epicardial ablation as a bailout in electrical storm? 72
Combined use of cryoballoon and focal open-irrigation radiofrequency ablation for treatment of persistent atrial fibrillation: Results from a pilot study 71
Ablation Index as a predictor of long-term efficacy in premature ventricular complex ablation: A regional target value analysis 69
Ventricular arrhythmias induced by long-term use of ephedrine in two competitive athletes 69
Exploring digenic inheritance in arrhythmogenic cardiomyopathy 69
Role of Intracardiac echocardiography in Atrial Fibrillation Ablation 69
Electroanatomic and histologic findings in patients with clinical and instrumental diagnosis of arrhythmogenic right ventricular cardiomyopathy 69
Rationale and design of the NO-PARTY trial: Near-zero fluoroscopic exposure during catheter ablation of supraventricular arrhythmias in young patients 68
Cardiac resynchronization therapy in patients with mild heart failure: A systematic review and meta-analysis 66
Prevalence and clinical significance of collateral findings detected by chest computed tomography in patients undergoing atrial fibrillation ablation 66
An ablation index operator-independent approach to improve efficacy in atrial fibrillation ablation at 24-month follow-up: a single center experience 66
Ablation for longstanding permanent atrial fibrillation: Results from a randomized study comparing three different strategies 66
Concealed cardiomyopathies in competitive athletes with ventricular arrhythmias and an apparently normal heart: Role of cardiac electroanatomical mapping and biopsy 66
Ablation of perimitral flutter following catheter ablation of atrial fibrillation: Impact on outcomes from a randomized study (PROPOSE) 65
Long term follow up after radiofrequency catheter ablation of atrial fibrillation: role of the acute procedure outcome and of the clinical presentation 65
Fibrosis in Arrhythmogenic Cardiomyopathy: The Phantom Thread in the Fibro-Adipose Tissue 64
Acute outcome after a single cryoballoon ablation: Comparison between Arctic Front Advance and Arctic Front Advance PRO 63
Difficult case of a trans-septal puncture: Use of a "SafeSept" guidewire 63
Scar Homogenization Versus Limited-Substrate Ablation in Patients With Nonischemic Cardiomyopathy and Ventricular Tachycardia 63
Feasibility of Combined Unipolar and Bipolar Voltage Maps to Improve Sensitivity of Endomyocardial Biopsy 62
A Closer Look at Incidental Findings on Cardiac Computed Tomography 62
Derivation of human induced pluripotent stem cell line EURACi004-A from skin fibroblasts of a patient with Arrhythmogenic Cardiomyopathy carrying the heterozygous PKP2 mutation c.2569_3018del50 62
Catheter ablation of atrial fibrillation: Randomized controlled trials and registries, a look back and the view forward 62
Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: A systematic review and meta-analysis 61
Heart rate turbulence: An useful non invasive risk predictor in patients with myotonic dystrophy type 1 61
pregnant women with drug-refractory supraventricular tachyarrhythmias. Catheter ablation during pregnancy 61
HEART RATE VARIABILITY AND THE SUBSTRATE FOR VENTRICULAR TACHYCARDIA IN ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 60
Pulmonary-vein isolation for atrial fibrillation in patients with heart failure 59
Novel Application of 3-Dimensional Real-Time Cardiac Imaging to Guide Stem Cell-Based Therapy 59
Letter by santangeli et al regarding article, high-density substrate mapping in brugada syndrome: Combined role of conduction and repolarization heterogeneities in arrhythmogenesis 59
Right ventricular substrate mapping using the Ensite Navx system: Accuracy of high-density voltage map obtained by automatic point acquisition during geometry reconstruction 58
Ablation of Stable VTs Versus Substrate Ablation in Ischemic Cardiomyopathy the VISTA Randomized Multicenter Trial 58
The effects of gender on electrical therapies for the heart: Procedural considerations, results and complications 58
Uncommon ventricular tachycardia originating from an interventricular septal aneurism: Mapping and ablation guided by real-time image integration 58
Clinical and inflammatory predictors of occurrence of ventricular tachycardia and ventricular fibrillation in madit II-like patients 58
Electroanatomical mapping systems and intracardiac echo integration for guided endomyocardial biopsy 57
The Growing Culture Of A Minimally Fluoroscopic Approach In Electrophysiology Lab 57
Long-Term Outcomes of Near-Zero Radiation Ablation of Paroxysmal Supraventricular Tachycardia: A Comparison With Fluoroscopy-Guided Approach 57
Proven isolation of the pulmonary vein antrum with or without left atrial posterior wall isolation in patients with persistent atrial fibrillation 56
Radiofrequency catheter ablation of electrical storm: A therapeutic choice 56
An atlas of radioscopic catheter placement for the electrophysiologist 55
Atrial fibrillation ablation strategies for paroxysmal patients randomized comparison between different techniques 55
Heart rate turbulence as a noninvasive risk predictor of ventricular tachyarrhythmias in myotonic dystrophy type 1 55
X-ray exposure in cardiac electrophysiology: A retrospective analysis in 8150 patients over 7 years of activity in a modern, large-volume laboratory 55
Radiofrequency catheter ablation for drug-refractory atrial fibrillation: Segmental pulmonary vein isolation versus antral pulmonary vein isolation through electroanatomic cartomerge or NAVX Verismo approach 55
Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial 54
Nationwide survey on the current practice of ventricular tachycardia ablation 54
Comparison of cardiac computed tomography versus cardiac magnetic resonance for characterization of left atrium anatomy before radiofrequency catheter ablation of atrial fibrillation 54
"NEAR ZERO" FLUOROSCOPIC EXPOSURE IN SUPRAVENTRICULAR ARRHYTHMIA ABLATION USING THE ENSITE NAVXTM MAPPING SYSTEM 54
Ablation Index Predicts Successful Ablation of Focal Atrial Tachycardia: Results of a Multicenter Study 53
Electrical storm: A clinical and electrophysiological overview 53
Evaluation of heart rate variability, late ventricular potentials, and inducibility of ventricular tachycardia in patients with myotonic dystrophy type 1 53
Endomyocardial biopsy in the hands of the electrophysiologist: the ‘one-stop shop’ for arrhythmic non-ischaemic cardiomyopathy. Letter regarding the article ‘Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy’ 53
Left atrial appendage: An underrecognized trigger site of atrial fibrillation 52
Safety and effectiveness of transvenous lead extraction in octogenarians 52
Long-term follow-up analysis of a highly characterized arrhythmogenic cardiomyopathy cohort with classical and non-classical phenotypes-a real-world assessment of a novel prediction model: does the subtype really matter 52
Detection of concealed structural heart disease by imaging in patients with apparently idiopathic premature ventricular complexes: A review of current literature 52
Usefulness of intracardiac echocardiography for the diagnosis of cardiovascular implantable electronic device-related endocarditis 51
Left Atrial Appendage Isolation in Patients With Longstanding Persistent AF Undergoing Catheter Ablation: BELIEF Trial 51
Characterization of the electroanatomic substrate in a case of noncompaction left ventricle 51
Near zerO fluoroscopic exPosure during catheter ablAtion of supRavenTricular arrhYthmias: The NO-PARTY multicentre randomized trial 51
Analysis of catheter contact force during atrial fibrillation ablation using the robotic navigation system: results from a randomized study 51
Comparison of atrial fibrillation ablation strategies for paroxysmal patients presenting to the electrophysiology laboratory in atrial fibrillation 51
Association of Premature Ventricular Contraction Burden on Serial Holter Monitoring With Arrhythmic Risk in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy 50
Isolation and characterization of cardiac mesenchymal stromal cells from endomyocardial bioptic samples of arrhythmogenic cardiomyopathy patients 50
Correlation between signal-averaged ecg and the histologic evaluation of the myocardial substrate in right ventricular outflow tract arrhythmias 50
Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: The impact of periprocedural therapeutic international normalized ratio 49
Impact of pre-existent areas of complex fractionated atrial electrograms on outcome after pulmonary vein isolation 49
Lesion index: a novel guide in the path of successful pulmonary vein isolation. 49
null 49
Utility and safety of mesh mapper catheter for pulmonary vein disconnection in paroxysmal atrial fibrillation 49
Results from a single-blind, randomized study comparing the impact of different ablation approaches on long-term procedure outcome in coexistent atrial fibrillation and flutter (approval) 48
Atrial fibrillation and the risk of incident dementia: A meta-analysis 48
Cardiac mesenchymal stromal cells are a source of adipocytes in arrhythmogenic cardiomyopathy 48
Long-term outcomes and mode of recurrences with endo-epicardial homogeneization of the scar versus limited substrate ablation for electrical storms in patients with ischemic cardiomyopathy 48
Additional diagnostic value of cardiac magnetic resonance feature tracking in patients with biopsy-proven arrhythmogenic cardiomyopathy 48
null 48
Recurrence of atrial fibrillation post-ablation: which is the most effective approach for detection? 47
Intraventricular conduction abnormalities in young patients with type 1 diabetes mellitus 47
Feasibility and safety of catheter ablation of electrical storm in ischemic dilated cardiomyopathy 47
Sports Activity and Arrhythmic Risk in Cardiomyopathies and Channelopathies: A Critical Review of European Guidelines on Sports Cardiology in Patients with Cardiovascular Diseases 47
Long-term complications in patients implanted with subcutaneous implantable cardioverter-defibrillators: Real-world data from the extended ELISIR experience 47
Totale 6.495
Categoria #
all - tutte 85.694
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.694


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020724 0 0 0 0 0 0 0 27 208 66 50 373
2020/20213.012 204 270 454 52 450 221 206 212 252 272 252 167
2021/20221.510 151 354 34 37 81 83 77 97 109 97 131 259
2022/20233.108 226 163 187 242 127 1.108 11 166 635 20 128 95
2023/20241.813 273 43 149 172 302 442 36 67 41 92 22 174
2024/20251.109 160 447 198 60 139 105 0 0 0 0 0 0
Totale 11.276